Lifestyle and dietary interventions for Ménière’s disease

Autor: Webster, KE, George, B, Lee, A, Galbraith, K, Harrington-Benton, NA, Judd, O, Kaski, D, Maarsingh, OR, MacKeith, S, Murdin, L, Ray, J, Van Vugt, VA, Burton, MJ

Publikováno v: Cochrane Database of Systematic Reviews, 2023(2):CD015244. John Wiley and Sons Ltd
Webster, K E, George, B, Lee, A, Galbraith, K, Harrington-Benton, N A, Judd, O, Kaski, D, Maarsingh, O R, MacKeith, S, Murdin, L, Ray, J, Van Vugt, V A & Burton, M J 2023, ' Lifestyle and dietary interventions for Ménière's disease ', Cochrane Database of Systematic Reviews, vol. 2023, no. 2, CD015244 . https://doi.org/10.1002/14651858.CD015244.pub2
Webster, K E, George, B, Lee, A, Galbraith, K, Harrington-Benton, N A, Judd, O, Kaski, D, Maarsingh, O R, MacKeith, S, Murdin, L, Ray, J, van Vugt, V A & Burton, M J 2023, ' Lifestyle and dietary interventions for Ménière's disease ', Cochrane Database of Systematic Reviews, vol. 2023, no. 2, CD015244, pp. CD015244 . https://doi.org/10.1002/14651858.CD015244.pub2

BACKGROUND: Ménière's disease is a condition that causes recurrent episodes of vertigo, associated with hearing loss and tinnitus. Lifestyle or dietary modifications (including reducing the amount of salt or caffeine in the diet) are sometimes sugg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43bb2458cff4a13d0249e72aa3db54fb
https://doi.org/10.1002/14651858.cd015244.pub2

Surgical interventions for Ménière’s disease

Autor: Lee, A, Webster, KE, George, B, Harrington-Benton, NA, Judd, O, Kaski, D, Maarsingh, OR, MacKeith, S, Ray, J, Van Vugt, VA, Burton, MJ

Publikováno v: Lee, A, Webster, K E, George, B, Harrington-Benton, N A, Judd, O, Kaski, D, Maarsingh, O R, MacKeith, S, Ray, J, van Vugt, V A & Burton, M J 2023, ' Surgical interventions for Ménière's disease ', Cochrane Database of Systematic Reviews, vol. 2023, no. 2, CD015249, pp. CD015249 . https://doi.org/10.1002/14651858.CD015249.pub2
Cochrane Database of Systematic Reviews, 2023(2):CD015249. John Wiley and Sons Ltd

BACKGROUND: Ménière's disease is a condition that causes recurrent episodes of vertigo, associated with hearing loss and tinnitus. First-line treatments often involve dietary or lifestyle changes, medication or local (intratympanic) treatments. How

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6965d1eeac9cfc73151480372c8efc1a
https://ora.ox.ac.uk/objects/uuid:11351320-160f-4d99-9411-3ae4b435fa4f

Topical and oral steroids for otitis media with effusion (OME) in children.

Autor: Mulvaney CA; Cochrane ENT, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Galbraith K; Cochrane ENT, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Webster KE; Cochrane ENT, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Rana M; ENT Department, Frimley Health NHS Foundation Trust, Slough, UK., Connolly R; National Institute for Health and Care Excellence, London, UK., Tudor-Green B; Department of Otorhinolaryngology - Head & Neck Surgery, University Hospitals Plymouth NHS Trust, Plymouth, UK., Marom T; Department of Otolaryngology - Head and Neck Surgery, Samson Assuta Ashdod University Hospital, Ben Gurion University Faculty of Health Sciences, Ashdod, Israel., Daniel M; Nottingham Children's Hospital, Nottingham, UK., Venekamp RP; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Schilder AG; evidENT, Ear Institute, University College London, London, UK.; NIHR UCLH Biomedical Research Centre, University College London, London, UK., MacKeith S; ENT Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Publikováno v: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2023 Dec 13; Vol. 12. Cochrane AN: CD015255. Date of Electronic Publication: 2023 Dec 13.

Antibiotics for otitis media with effusion (OME) in children.

Autor: Mulvaney CA; Cochrane ENT, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Galbraith K; Cochrane ENT, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Webster KE; Cochrane ENT, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Rana M; ENT Department, Frimley Health NHS Foundation Trust, Slough, UK., Connolly R; National Institute for Health and Care Excellence, London, UK., Marom T; Department of Otolaryngology-Head and Neck Surgery, Samson Assuta Ashdod University Hospital, Ben Gurion University Faculty of Health Sciences, Ashdod, Israel., Daniel M; Nottingham Children's Hospital, Nottingham, UK., Venekamp RP; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Schilder AG; evidENT, Ear Institute, University College London, London, UK.; NIHR UCLH Biomedical Research Centre, University College London, London, UK., MacKeith S; ENT Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Publikováno v: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2023 Oct 23; Vol. 10. Cochrane AN: CD015254. Date of Electronic Publication: 2023 Oct 23.

Autoinflation for otitis media with effusion (OME) in children.

Autor: Webster KE; Cochrane ENT, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Mulvaney CA; Cochrane ENT, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Galbraith K; Cochrane ENT, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Rana M; ENT Department, Frimley Health NHS Foundation Trust, Slough, UK., Marom T; Department of Otolaryngology - Head and Neck Surgery, Samson Assuta Ashdod University Hospital, Ben Gurion University Faculty of Health Sciences, Ashdod, Israel., Daniel M; Nottingham Children's Hospital, Nottingham, UK., Venekamp RP; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Schilder AG; evidENT, Ear Institute, University College London, London, UK.; NIHR UCLH Biomedical Research Centre, University College London, London, UK., MacKeith S; ENT Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Publikováno v: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2023 Sep 26; Vol. 9. Cochrane AN: CD015253. Date of Electronic Publication: 2023 Sep 26.